Becton Dickinson blood specimen collection - supply disruption

An update has been issued in relation to the supply disruption to Becton Dickinson's (BD) blood specimen collection portfolio, further to the previous letter sent on 16 September. 

Due to the mitigations in place and the efforts of colleagues across the NHS the supply situation has stabilised but with supplies not yet back at normal levels. To reflect the current position, and to avoid putting further pressure on stock, as the situation continues to recover, changes to the guidance issued on 16 September have been made that take place from 8 October 2021.

This alert contains further information and action for providers.